IDev Technologies, Inc. Closes $25 Million Financing

HOUSTON - (Business Wire) IDev Technologies, Inc., an emerging leader in the development and marketing of minimally invasive stent systems for the treatment of peripheral vascular and non-vascular diseases, today announced that it has closed a $25 million Series C round of financing. The financing was secured entirely by existing investors which include: PTV Lifesciences, Rivervest Venture Partners, Bay City Capital, Heron Capital, members of the senior management team, corporate advisors to the company and initial independent investors.
Thomas M. Tully, Chairman and CEO commented, “We are very pleased to have completed this round of financing as we enter into the full commercialization phase of the SUPERA® Transhepatic Biliary System. We also continue to be steadfast in our clinical trial and regulatory initiatives. The unanimous support from our existing investor base is just one indicator of the exceptional business opportunity that exists for this organization.”
full article >> http://www.earthtimes.org/articles/show/idev-technologies-inc-closes-25-million-financing,361087.shtml